Obesity is America’s #1 underlying health issue.
Because it causes or increases the likelihood of over 100 other health conditions.
Now, Isabelle Kenyon is out to change the way the world treats weight.
She’s Founder & CEO of Calibrate, the VC-backed medical metabolic health company.
It’s creating a new category by improving metabolic health to drive long-term, sustainable weight loss with a program designed by world leaders in obesity & nutrition science.
This is the first direct-to-consumer telemedicine business aligning incentives for doctors, insurers, pharmaceutical companies, and consumers.
Calibrate combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions that drive lasting behavior change.
Prior to Calibrate, Isabelle led the business operations, growth, and strategic partnerships & communications teams at Capsule, a technology business that is rebuilding the pharmacy from the inside out.
Clearly, she’s onto something big.
She recently closed a $22.5 million round of venture capital including Threshold Ventures, Redesign Health, and Forerunner Ventures.
In this 20-minute conversation, Isabelle reveals how she’s putting a Rockstar in every seat at Calibrate